Sex Differences in Migraine

Size: px
Start display at page:

Download "Sex Differences in Migraine"

Transcription

1 Sex Differences in Migraine European Before puberty (10-14 girls), migraine affects both sexes equally Following puberty, migraine has strikingly higher prevalence in females than in men Female:male ratio 2:1 to 3:1, peaks at midlife Female migraineurs have more symptoms (photophobia, nausea) and more migrainerelated disability than male migraineurs Female predominance consistent across racial groups American Migraine Prevalence and Prevention Study (160,000 participants) Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, Serrano D, Lipton RB. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache Sep;53(8): Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J. Epidemiology of headache in Europe. Eur J Neurol Apr;13(4):

2 Sexual Dimorphism in Familial Hemiplegic Migraine Rare autosomal dominant migraine with aura Danish study identified 147 affected FHM patients from 44 families Most often had all 4 typical aura symptoms: visual, sensor, aphasic, motor Headache present in 99% of FHM patients during attack Female (105) : male (42) = 2.5 Thomsen LL, Eriksen MK, Roemer SF, Andersen I, Olesen J, Russell MB. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain Jun;125(Pt 6):

3 Menstrual Migraine >50% of women with migraine report an association between migraine and menstruation Only migraine without aura Incidence greatest 2 days before menstruation and continuing through day 2-3 of bleeding More severe, disabling, and refractory to abortive medications than non-menstrually related IHS Menstrual migraine = attacks of migraine without aura which occur on day 1 ± 2 (i.e. days 2 to +3) of menstruation in at least 2/3 menstrual cycles (affects approximately 20% female migraineurs) [1st day of menstruation is day 1; no day 0]

4 Sex Steroids During Menstrual Cycle and Menstrual Migraine Menstruation Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology Apr;22(4):

5 Treatment with Progresterone Does Not Affect Menstrual Migraine Daily injections of progesterone (25-75 mg) in sesame oil beginning 3-6 days before the expected onset of menstruation, adjusted to maintain plasma progesterone of 5-20 ng/ml (midluteal range) Somerville BW. The influence of progesterone and estradiol upon migraine. Headache Oct;12(3):

6 Treatment with Estradiol Delays Menstrual Migraine Estradiol valerate in oil (slowrelease estradiol), 10 mg, i.m., 3-6 days before expected onset of menstrual bleeding Plasma estradiol threshold = 0.05 ng/ml Somerville BW. The influence of progesterone and estradiol upon migraine. Headache Oct;12(3):

7 Incidence of Migraine Relative to Menstrual Cycle Phases Luteal Onset of menstruation Follicular 38 women with 1-4 migraine attacks/month, 1 of which occurred perimenstrually Urinary metabolites collected daily Higher number of attacks late luteal/early follicular phase Lower number of attack during rising estrogen No increased migraine in relation to postovulatory withdrawal MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology Dec 26;67(12):

8 Menopause Last menstrual period around age 51 In perimenopausal years, orderly pattern of estrogen and progesterone secretion is lost Following menopause, lower levels of hormones fluctuate for 4-5 years; migraine may worsen but often progressively improves over time Migraine with aura unaffected by menopause Freeman EW, Sammel MD, Lin H, Gracia CR, Kapoor S. Symptoms in the menopausal transition: hormone and behavioral correlates. Obstet Gynecol Jan;111(1):

9 In postmenopausal women, fall in estrogen after 5 mg depo-estradiol triggers migraine in those with history of severe menstrual migraine but not in normal controls Sustained estrogen exposure necessary for estrogen withdrawal to provoke migraine attacks. Threshold estrogen (0.05 ng/ml) same as in Somerville s studies. Lichten EM, Lichten JB, Whitty A, Pieper D. The confirmation of a biochemical marker for women's hormonal migraine: the depo-estradiol challenge test. Headache Jun;36(6):

10 Pregnancy Kvisvik EV, Stovner LJ, Helde G, Bovim G, Linde M. Headache and migraine during pregnancy and puerperium: the MIGRA-study. J Headache Pain. 2011;15(4):

11 Cortical Spreading Depression Depolarization Decreased blood flow [Dhir A, Lossin C, Rogawski MA. Neuroscience Lett 514: 67 70, 2012]

12

13 Reduced CSD Threshold in Female Mice KCl Stimulation Tetanic Stimulation Brennan KC, Romero Reyes M, López Valdés HE, Arnold AP, Charles AC. Reduced threshold for cortical spreading depression in female mice. Ann Neurol Jun;61(6):603-6.

14 Sex Differences in CSD in FHM Type 1 Mouse (R192Q mutation) Homozygous R192Q CACNA1A gene (α1a subunit of Cav2.1 channels) R192Q causes mild CSD Topical KCl used to evoke CSD Eikermann-Haerter K, Dileköz E, Kudo C, Savitz SI, Waeber C, Baum MJ, Ferrari MD, van den Maagdenberg AM, Moskowitz MA, Ayata C. Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Invest Jan;119(1):

15 Testosterone Suppresses CSD in FHM Type 1 Mouse (R192Q mutation) Subcutaneous testosterone pellet (0.1 mg/pellet, 21-day release) Testosterone propionate (1.2 mg) Subcutaneous flutamide (25 or 50 mg/pellet, 21-day release Eikermann-Haerter K, Baum MJ, Ferrari MD, van den Maagdenberg AM, Moskowitz MA, Ayata C. Androgenic suppression of spreading depression in familial hemiplegic migraine type 1 mutant mice. Ann Neurol Oct;66(4):564-8.

16 Case Report: Menstrual Hemiplegic Migraine Cured by Oophorectomy 48-year-old woman with premenstrual right arm and leg weakness, expressive dysphasia TAH-BSO Completely well with no subsequent recurrence of symptoms Sood SV. Hemiplegic migraine associated with menstruation. J Obstet Gynaecol Br Commonw Aug;78(8):762-3.

17 MM Perimenstrual Prophylaxis (NSAIDs) Naproxen (550 mg) b.i.d., 7-14 days, starting during the week before expected onset of menstruation Risks: GI bleeding (consider gastroduodenal protection) Medication-overuse headache Fluid retention, edema hypertension

18 MM Perimenstrual Prophylaxis (triptans) Frovatriptan (load: 5 mg b.i.d. first day; 2.5 mg b.i.d. remaining days), 6 days, starting 2 days before expected onset of menstruation Naratriptan and zolmitriptan can also be used 2 hour recurrence MacGregor EA. A review of frovatriptan for the treatment of menstrual migraine. Int J Womens Health May 21;6:

19 MM Estrogen Supplements Maintains luteal phase estradiol levels, preventing late luteal phase drop Women must be menstruating regularly (endogenous progesterone following ovulation provides endometrial protection) Estradiol gel 1.5 mg (1.5 g) daily, 7 days, starting between 2-5 days before expected onset of menstruation Estradiol transdermal system Estradiol Gel Estradiol transdermal system (Vivelle Dot)

20 Contraceptives Progestin Only Ethinylestradiol-containing BCP s contraindicated in migraine with aura due to 2-fold increased stroke risk; also contraindicated in clotting disorder, history of DVT, or cardiovascular risk factors (lipids, obesity, smoking, CRP) Progesterone only BCPs ( mini-pill ) safe alternative Mini-Pill: Micronor, Nor-QD (norethindrone) Implant (3 year): Implanon, Nexplanon (etonogestrel) Depo: Depo-provera (medroxyprogesterone) Higher failure rate and slightly higher rate of ectopic pregnancy Alternatives: IUD, barrier contraceptives Levonorgestrel IUD (low systemic absorption) (Mirena, Skyla)

21 MM Oral Contraceptives Oral contraceptives can be used to prevent pregnancy in most women with migraine; do not prevent migraine Risks of endometrial and ovarian cancer reduced; possibly reduce colon cancer risk Risk of breast, cervical, and liver cancer increased Estrogen withdrawal during hormone-free interval can trigger migraine Estrogen supplements can prevent (0.01 mg oral ethinyl estradiol, 0.9 mg oral conjugated equine estrogens, 0.1 mg/day estradiol patch, 2 g estradiol gel) Endometrial protection from progestagen in BCP

22 MM Monophasic (Continuous) Low-Dose Combination Oral Contraceptives Reduced Withdrawal Bleeds / Amenorrhea Contraceptive-induced amenorrhea reduces migraine frequency 84/7 regimen (4 withdrawal bleeds; Seasonique) No withdrawal bleeds (Lybrel; unscheduled bleeding in early cycles resolves with time; may break with the bleed - stop BCP for 3 days); by months continuous use, % of women are amenorrheic Vetvik KG, MacGregor EA, Lundqvist C, Russell MB. Contraceptive-induced amenorrhoea leads to reduced migraine frequency in women with menstrual migraine without aura. J Headache Pain May 17;15:30.

23 MM Chemical Menopause: Leuprolide + add-back Leuprolide acetate 3.75 mg IM monthly Last 6 months estrogenprogestin add-back transdermal estradiol (E2) patches (0.1 mg/d) and oral medroxyprogesterone acetate (2.5 mg daily Provera) Murray SC, Muse KN. Effective treatment of severe menstrual migraine headaches with gonadotropinreleasing hormone agonist and add-back therapy. Fertil Steril 1997;67(2):390Y393.

24 Perimenopause Many women require treatment for vasomotor symptoms, usually with hormone replacement Oral estrogen can exacerbate migraine Non-oral routes: estradiol gel, estradiol transdermal system Endometrial protection with progestin necessary for women who have not had hysterectomy Medroxyprogesterone acetate (2.5 mg/day) Natural progesterone ( mg/day) Levonorgestrel IUD (low systemic absorption) (Mirena, Skyla) 4% vaginal progesterone (Crinone) -- must apply daily, expensive MacGregor EA. Migraine Management During Menstruation and Menopause. Continuum (Minneap Minn) Aug;21(4 Headache): Hampton NR, Rees MC, Lowe DG, Rauramo I, Barlow D, Guillebaud J. Levonorgestrel intrauterine system (LNG-IUS) with conjugated oral equine estrogen: a successful regimen for HRT in perimenopausal women. Hum Reprod Sep;20(9): Levonorgestrel-releasing intrauterine system (LNG-IUS; Mirena) Copper IUD (Paragard)

25 The End

Jessica Ailani MD FAHS Director, Georgetown Headache Center Associate Professor Neurology Medstar Georgetown University Hospital

Jessica Ailani MD FAHS Director, Georgetown Headache Center Associate Professor Neurology Medstar Georgetown University Hospital Jessica Ailani MD FAHS Director, Georgetown Headache Center Associate Professor Neurology Medstar Georgetown University Hospital Honorarium from Current Pain and Headache Reports; Section Editor Unusual

More information

Disclosures. Learning Objectives. Treatment Of Menstrual Migraine 11/10/2017. Research grants Aralez, Allergan

Disclosures. Learning Objectives. Treatment Of Menstrual Migraine 11/10/2017. Research grants Aralez, Allergan Treatment Of Menstrual Migraine Christine Lay, MD Director, Centre for Headache Associate Professor University of Toronto Disclosures Research grants Aralez, Allergan Unrestricted educational grants Aralez,

More information

HRT in Perimenopausal Women. Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College

HRT in Perimenopausal Women. Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College HRT in Perimenopausal Women Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College 1 This is the Change But the CHANGE is not a disease 2 Introduction With a marked increase in longevity, women now

More information

Picking the Perfect Pill How to Effectively Choose an Oral Contraceptive

Picking the Perfect Pill How to Effectively Choose an Oral Contraceptive Focus on CME at Queen s University Picking the Perfect Pill How to Effectively Choose an Oral Contraceptive By Susan Chamberlain, MD, FRCSC There are over 20 oral contraceptive (OC) preparations on the

More information

Contraception: Common Problems Faced in Office Practice. Jane S. Sillman, MD Brigham and Women s Hospital

Contraception: Common Problems Faced in Office Practice. Jane S. Sillman, MD Brigham and Women s Hospital Contraception: Common Problems Faced in Office Practice Jane S. Sillman, MD Brigham and Women s Hospital Disclosures I have no conflicts of interest Contraception: Common Problems How to discuss contraception

More information

Progestin-only methods Type or dose of progestagen

Progestin-only methods Type or dose of progestagen Progestin-only contraception and beneficial effects on migraine Conflicts of interest A d v ise r a n d le ctu re r fo r E X E LT IS Le ctu re s a n d A d v iso ry b o a rd s B aye r Le ctu re s a n d

More information

When acute therapies of menstrually

When acute therapies of menstrually PREVENTIVE TREATMENT OF MENSTRUALLY RELATED MIGRAINE * Stephen D. Silberstein, MD, FACP ABSTRACT Preventive treatment of menstrually related migraine (MRM) is initiated when acute therapies fail to provide

More information

The 45-year-old woman with monthly headaches. Anne MacGregor Barts and the London School of Medicine and Dentistry

The 45-year-old woman with monthly headaches. Anne MacGregor Barts and the London School of Medicine and Dentistry The 45-year-old woman with monthly headaches Anne MacGregor Barts and the London School of Medicine and Dentistry Learning Objectives Use of diary cards for establishing patterns of attacks Importance

More information

Time Topic Speaker Abbreviation

Time Topic Speaker Abbreviation 1. Programme Sunday, 4 th November 2018 Time Topic Speaker Abbreviation 08:00 Welcome, distribution materials 08:30 Overview of the Medical Eligibility Criteria (2015), and the Selected Practices Recommendations

More information

What s New in Adolescent Contraception?

What s New in Adolescent Contraception? What s New in Adolescent Contraception? Abby Furukawa, MD Legacy Medical Group Portland Obstetrics and Gynecology April 29, 2017 Objectives Provide an update on contraception options for the adolescent

More information

Contraception for Obese Women RENEE E. MESTAD, MD, MSCI ACOG DISTRICT II UPSTATE MEETING APRIL 29, 2016

Contraception for Obese Women RENEE E. MESTAD, MD, MSCI ACOG DISTRICT II UPSTATE MEETING APRIL 29, 2016 Contraception for Obese Women RENEE E. MESTAD, MD, MSCI ACOG DISTRICT II UPSTATE MEETING APRIL 29, 2016 Disclosure I am a Nexplanon trainer for Merck. Objectives Understand how obesity may affect pharmacokinetics

More information

WHAT ARE CONTRACEPTIVES?

WHAT ARE CONTRACEPTIVES? CONTRACEPTION WHAT ARE CONTRACEPTIVES? Methods used to prevent fertilization *Also referred to as birth control methods With contraceptives, it is important to look at what works for you and your body.

More information

Peggy Piascik, PhD Associate Professor, Pharmacy Practice and Science

Peggy Piascik, PhD Associate Professor, Pharmacy Practice and Science Peggy Piascik, PhD Associate Professor, Pharmacy Practice and Science Department, UK College of Pharmacy Describe extended cycle oral contraceptive characteristics including dosing regimen, indications,

More information

Medical Eligibility for Contraception Use

Medical Eligibility for Contraception Use Medical Eligibility for Contraception Use DIVISION OF REPRODUCTIVE HEALTH CENTERS FOR DISEASE CONTROL AND PREVENTION 2016 US Medical Eligibility Criteria for Contraceptive Use (US MEC) Purpose To assist

More information

Headache ISSN Ovarian Hormones and Migraine Headache: Understanding Mechanisms and Pathogenesis Part 2

Headache ISSN Ovarian Hormones and Migraine Headache: Understanding Mechanisms and Pathogenesis Part 2 Headache ISSN 0017-8748 C 2006 by American Headache Society doi: 10.1111/j.1526-4610.2006.00370.x Published by Blackwell Publishing Review Article Ovarian Hormones and Migraine Headache: Understanding

More information

Contraception. Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine

Contraception. Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine Contraception Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine Disclosures No financial relationships to disclose I have no commercial, financial, research ties to

More information

prevalence was 13.8% among females

prevalence was 13.8% among females 1 2 3 1. Woldeamanuel YW et al. Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of communitybased studies involving 6 million participants. J Neurol

More information

Topic 24: Estrogens and Female Reproductive Drugs

Topic 24: Estrogens and Female Reproductive Drugs Topic 24: Estrogens and Female Reproductive Drugs I. Contraceptives A. Estrogen-Progestin Contraceptives Note all of these drugs contain one estrogen (listed first) and one progestin Drug to know: ethinyl

More information

Thrombosis and Women s Health Risk factors, contraceptive pill, HRT and your doctor

Thrombosis and Women s Health Risk factors, contraceptive pill, HRT and your doctor Thrombosis and Women s Health Risk factors, contraceptive pill, HRT and your doctor Dr Matthew Fay GP Principal The Willows Medical Practice- Queensbury GPwSI and Co-Founder Westcliffe Cardiology Service

More information

Women s Issues in Epilepsy. Esther Bui, Epilepsy Fellow MD, FRCPC

Women s Issues in Epilepsy. Esther Bui, Epilepsy Fellow MD, FRCPC Women s Issues in Epilepsy Esther Bui, Epilepsy Fellow MD, FRCPC How are women different? Different habitus Different metabolism Different co-morbidities Different psychosocial stigma Different hormonal

More information

Learning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories

Learning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories Learning Objectives Identify common symptoms of the menopause transition Understand the risks and benefits of hormone replacement therapy (HRT) Be able to choose an appropriate hormone replacement regimen

More information

Estrogens & Antiestrogens

Estrogens & Antiestrogens Estrogens & Antiestrogens Menstrual cycle... Changes and hormonal events Natural estrogens: Estadiol >> Estrone > Estriol Ineffective orally Synthesis: From cholesterol ; role of aromatase enzyme in converting

More information

Abnormal Uterine Bleeding Case Studies

Abnormal Uterine Bleeding Case Studies Case Study 1 Abnormal Uterine Bleeding Case Studies Abigail, a 24 year old female, presents to your office complaining that her menstrual cycles have become a problem. They are now lasting 6 7 days instead

More information

Clinical Challenges in Contraception. Disclosures. Objectives Pharmacists 4/3/2018

Clinical Challenges in Contraception. Disclosures. Objectives Pharmacists 4/3/2018 Clinical Challenges in Contraception Kathleen Besinque, PharmD Sarah McBane, PharmD Disclosures Kathleen Besinque has nothing to disclose Sarah McBane has nothing to disclose Objectives Pharmacists Compare

More information

Instruction for the patient

Instruction for the patient WS 4 Case 3 STI and IUD Your situation Instruction for the patient You are 32 years old, divorced and have one child; you have just started a new relationship You underwent surgical resection of the left

More information

2/4/2011. What is your specialty? A. Family practice B. Internal medicine and subs C. OB/GYN D. Peds E. Surgery and subs

2/4/2011. What is your specialty? A. Family practice B. Internal medicine and subs C. OB/GYN D. Peds E. Surgery and subs Steve P. Buchanan D.O. FACOOG(Dist.) TOMA Mid Winter February 11, 2011 Dallas,TX Associate Professor OB/GYN UNTHSC/TCOM 1987- present Executive Vice President, American College of Osteopathic Obstetricians

More information

Update on Medical and Surgical Therapy Sara Jane Pieper, MD Chair, Gynecology Development Team

Update on Medical and Surgical Therapy Sara Jane Pieper, MD Chair, Gynecology Development Team ABNORMAL UTERINE BLEEDING Update on Medical and Surgical Therapy Sara Jane Pieper, MD Chair, Gynecology Development Team Goals Review appropriate medical therapies for abnormal uterine bleeding Review

More information

Taking provera with nexplanon

Taking provera with nexplanon Taking provera with nexplanon The Borg System is 100 % Taking provera with nexplanon Aug 31, 2015. Side effects for everyone are different, and the amount of time that it takes for your body to get used

More information

Ana Podgorac Belgrade, May 2012

Ana Podgorac Belgrade, May 2012 Headache and reproductive life Ana Podgorac Belgrade, May 2012 52 years old woman, English teacher in primary school, married, mother of two, with a history of migraine without aura. Over the last 6 months

More information

5. Summary of Data Reported and Evaluation

5. Summary of Data Reported and Evaluation 326 5. Summary of Data Reported and Evaluation 5.1 Exposure data Combined estrogen progestogen menopausal therapy involves the co-administration of an estrogen and a progestogen to peri- or postmenopausal

More information

Ardhanu Kusumanto Oktober Contraception methods for gyne cancer survivors

Ardhanu Kusumanto Oktober Contraception methods for gyne cancer survivors Ardhanu Kusumanto Oktober 2017 Contraception methods for gyne cancer survivors Background cancer treatment Care of gyn cancer survivor Promotion of sexual, cardiovascular, bone, and brain health management

More information

Dr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre

Dr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre Dr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre AUB Outline Terminology Classification/Etiology Assessment Treatment Referral to Gynaecology U c pt 4

More information

Topics. Periods Menopause & HRT Contraception Vulva problems

Topics. Periods Menopause & HRT Contraception Vulva problems Girls stuff Topics Periods Menopause & HRT Contraception Vulva problems Menorrhagia Excessive menstrual loss occurring with regular or irregular cycles Ovulatory Anovulatory Usual blood loss 30-40ml per

More information

Estrogens and progestogens

Estrogens and progestogens Estrogens and progestogens Estradiol and Progesterone hormones produced by the gonads are necessary for: conception embryonic maturation development of primary and secondary sexual characteristics at puberty.

More information

Women s Health: Managing Menopause. Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School

Women s Health: Managing Menopause. Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School Women s Health: Managing Menopause Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School Disclosures I have no conflicts of interest. Learning Objectives 1. Apply strategies to help

More information

Headaches are highly prevalent in

Headaches are highly prevalent in How to choose a contraceptive for a patient who has headaches Developing an accurate diagnosis of headache subtype will help avert unnecessary restriction of hormonal methods among your patients who do

More information

LONG-ACTING REVERSIBLE CONTRACEPTION. Summary Tables

LONG-ACTING REVERSIBLE CONTRACEPTION. Summary Tables LONG-ACTING REVERSIBLE CONTRACEPTION Summary Tables Bridging the Divide: A Project of the Jacobs Institute of Women s Health June 2016 Table 1. Summary of LARC Methods Available Years Since Effective Copper

More information

Hormone Products for Postmenopausal Use in the United States and Canada

Hormone Products for Postmenopausal Use in the United States and Canada Hormone Products for Postmenopausal Use in the United States and Canada Copyright The North American Menopause Society October 25, 2011 Table 1. Oral ET products for postmenopausal use in the United States

More information

100% Effective Natural Hormone Treatment Menopause, Andropause And Other Hormone Imbalances Impair Healthy Healing In People Over The Age Of 30!

100% Effective Natural Hormone Treatment Menopause, Andropause And Other Hormone Imbalances Impair Healthy Healing In People Over The Age Of 30! This Free E Book is brought to you by Natural Aging.com. 100% Effective Natural Hormone Treatment Menopause, Andropause And Other Hormone Imbalances Impair Healthy Healing In People Over The Age Of 30!

More information

LARC: Disclosures. Long Acting Reversible Contraception. Objectives 10/23/2013. I have no relevant financial disclosures

LARC: Disclosures. Long Acting Reversible Contraception. Objectives 10/23/2013. I have no relevant financial disclosures LARC: Long Acting Reversible Contraception Disclosures I have no relevant financial disclosures Jennifer Kerns, MD, MPH Assistant Professor, UCSF Obstetrics, Gynecology and Reproductive Sciences San Francisco

More information

Female Sexual Hormones Indications and Therapy

Female Sexual Hormones Indications and Therapy Female Sexual Hormones Indications and Therapy In puberty, a woman has about 400,000 ovules, at the age of 40-44 years about 17,000 only. On average, each grown-up woman (still having ovulation) loses

More information

The following lesson on contraception (birth control) is not intended to infer that you will be sexually active as a teen. This is information that

The following lesson on contraception (birth control) is not intended to infer that you will be sexually active as a teen. This is information that The following lesson on contraception (birth control) is not intended to infer that you will be sexually active as a teen. This is information that may be used in the future Abstinence Choosing not to

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle   holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/44385 holds various files of this Leiden University dissertation. Author: Ayata, C. Title: Spreading depolarizations : the missing link between mirgraine

More information

LUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi

LUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi LUTEAL PHASE SUPPORT Doç. Dr. Nafiye Yılmaz Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi TAJEV, 2014 1 ART & success *Live birth rate 2 Optimal luteal phase Etiology of luteal phase deficiency

More information

Diagnosis and management of menstrual migraine

Diagnosis and management of menstrual migraine Menstrual migraine z Review Diagnosis and management of menstrual migraine E Anne MacGregor MD, MFSRH, MICR The prevalence of migraine is highest during the peak reproductive years and many women report

More information

Table I. Examples of Hormone and Tapering Regimens

Table I. Examples of Hormone and Tapering Regimens Table I. Examples of Hormone and Tapering Regimens Severe AUB Heavy bleeding (soaking through 2 maxi pads an hour, 2 hours in a row) History of heavy menses Hemodynamically un (tachycardia, hypotensive,

More information

Female sex steroids and contraceptives agents

Female sex steroids and contraceptives agents Female sex steroids and contraceptives agents Female Sex Hormones Sex hormones produced by the gonads are necessary for conception, embryonic maturation, and development of primary and secondary sexual

More information

How Neurosteroids Modulate Seizures in Children and Adults November 30, 2012

How Neurosteroids Modulate Seizures in Children and Adults November 30, 2012 How Neurosteroids Modulate Seizures in Children and Adults November 30, 2012 Page B. Pennell, MD Brigham and Women s Hospital Harvard Medical School Boston, MA American Epilepsy Society Annual Meeting

More information

BLEEDING PATTERNS AND CONTRACEPTIVE DISCONTINUATION FG MHLANGA MTN ANNUAL MEETING 20 MARCH 2018

BLEEDING PATTERNS AND CONTRACEPTIVE DISCONTINUATION FG MHLANGA MTN ANNUAL MEETING 20 MARCH 2018 BLEEDING PATTERNS AND CONTRACEPTIVE DISCONTINUATION FG MHLANGA MTN ANNUAL MEETING 20 MARCH 2018 Introduction Bleeding with contraception may lead to discontinuation and possible unintended pregnancy What

More information

Hormonal Control of Human Reproduction

Hormonal Control of Human Reproduction Hormonal Control of Human Reproduction Bởi: OpenStaxCollege The human male and female reproductive cycles are controlled by the interaction of hormones from the hypothalamus and anterior pituitary with

More information

DR REBECCA LEVY-GANTT HOT TOPICS IN OBGYN 2018

DR REBECCA LEVY-GANTT HOT TOPICS IN OBGYN 2018 DR REBECCA LEVY-GANTT HOT TOPICS IN OBGYN 2018 2018 WHAT S NEW? Contraception: Long Acting reversible contraception Contraception: Birth control pills Vaginal dryness: Treatments Breast density: Diagnosis

More information

Appendix: Reference Table of HT Brand Names

Appendix: Reference Table of HT Brand Names Appendix: Reference Table of HT Brand Names This is a full reference table in alphabetical order, of Brand Name drugs used in HT. It is the basis for prescription advice throughout this handbook. Drug

More information

Complex Medical Problems? Complex Contraception. Objectives 4/17/2015. Sari Kives, MD,FRCSC ; Alene Toulany, MD, FRCPC

Complex Medical Problems? Complex Contraception. Objectives 4/17/2015. Sari Kives, MD,FRCSC ; Alene Toulany, MD, FRCPC Complex Medical Problems? Complex Contraception Sari Kives, MD,FRCSC ; Alene Toulany, MD, FRCPC Objectives Identify contraceptive options for an adolescent with Thrombophelia Diabetes SLE Migraines Epilepsy

More information

Menopause. Medicines To Help You

Menopause. Medicines To Help You Medicines To Help You Menopause Use this guide to help you talk to your doctor, pharmacist, or nurse about your hormone medicines. The guide lists all of the FDA-approved products now available to treat

More information

Contraception and gynecological pathologies

Contraception and gynecological pathologies 1 Contraception and gynecological pathologies 18 years old, 2 CMI normal First menstruation at 14 years old Irregular (every 2/3 months), painful + She does not need contraception She is worried about

More information

CURRENT HORMONAL CONTRACEPTION - LIMITATIONS

CURRENT HORMONAL CONTRACEPTION - LIMITATIONS CURRENT HORMONAL CONTRACEPTION - LIMITATIONS Oral Contraceptives - Features MERITS Up to 99.9% efficacy if used correctly and consistently Reversible method rapid return of fertility Offer non-contraceptive

More information

Learning objectives. Some fun facts. Presenter Disclosure Information. Become familiar with the newest contraceptive options available

Learning objectives. Some fun facts. Presenter Disclosure Information. Become familiar with the newest contraceptive options available 8:45 9:30 am Advances and Options in Female Contraception SPEAKER Pelin Batur, MD, FACP, NCMP, CCD Presenter Disclosure Information The following relationships exist related to this presentation: Pelin

More information

A Practitioner s Toolkit for the Management of the Menopause

A Practitioner s Toolkit for the Management of the Menopause Medicine, Nursing and Health Sciences A Practitioner s Toolkit for the Management of the Menopause Developed by the Women s Health Research Program School of Public Health and Preventive Medicine Monash

More information

Expanding Access to Birth Control: Will Women Get the Care They Need?

Expanding Access to Birth Control: Will Women Get the Care They Need? Expanding Access to Birth Control: Will Women Get the Care They Need? Target Audience: Pharmacists ACPE#: 0202-0000-18-045-L01-P Activity Type: Application-based Target Audience: ACPE#: Activity Type:

More information

Deciding whether or not to use Hormone Therapy (HT) is a big decision and should be

Deciding whether or not to use Hormone Therapy (HT) is a big decision and should be Deciding whether or not to use Hormone Therapy (HT) is a big decision and should be made with input from your healthcare provider. After the decision has been made to take HT, many women don t realize

More information

Progesterone. What is progesterone? Important information. Before taking this medicine

Progesterone. What is progesterone? Important information. Before taking this medicine Progesterone Generic Name: progesterone (proe JESS te rone) Brand Names: First Progesterone MC10, Menopause Formula Progesterone, Prometrium What is progesterone? Progesterone is a female hormone important

More information

UPDATE: Women s Health Issues

UPDATE: Women s Health Issues UPDATE: Women s Health Issues Renee B. Alexis, MD, MBA, MPH, FACOG Associate Professor Department of OBGYN Kiran C. Patel College of Osteopathic Medicine Disclosure of Conflicts of Interest I have no financial

More information

Unintended Pregnancy is Common LEARNING OBJECTIVES. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy And Contraceptive Use

Unintended Pregnancy is Common LEARNING OBJECTIVES. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy And Contraceptive Use 3:45 4:30 pm Beyond the Pill: Long Acting Contraceptives and IUDs Presenter Disclosure Information The following relationships exist related to this presentation: Christine L. Curry, MD, PhD: No financial

More information

Orals,Transdermals, and Other Estrogens in the Perimenopause

Orals,Transdermals, and Other Estrogens in the Perimenopause Orals,Transdermals, and Other Estrogens in the Perimenopause Cases Denise Black, MD, FRCSC Assistant Professor, Obstetrics, Gynecology and Reproductive Sciences University of Manitoba 6/4/18 197 Faculty/Presenter

More information

Menopause and HRT. John Smiddy and Alistair Ledsam

Menopause and HRT. John Smiddy and Alistair Ledsam Menopause and HRT John Smiddy and Alistair Ledsam Menopause The cessation of menstruation Diagnosed retrospectively after 1 year of amenorrhoea Average age 51 in the UK Normal physiology - Menstruation

More information

LEARNING OBJECTIVES. Beyond the Pill: Long Acting Contraception. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy is Common

LEARNING OBJECTIVES. Beyond the Pill: Long Acting Contraception. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy is Common 4:15 5 pm Beyond the Pill: Long Acting Contraceptives and IUDs Presenter Disclosure Information The following relationships exist related to this presentation: Christine L. Curry, MD, PhD: No financial

More information

Medications & Mothers Milk 2017

Medications & Mothers Milk 2017 See Monograph for Details Alesse, Aviane, Lessina, Levlite, Lutera, Sronyx Monophasic Ethinyl estradiol 20 mcg Levonorgestrel 0.1 mg Angeliq Monophasic Estradiol 1 mg Drospirenone 0.5 mg Approved in Europe

More information

Learning objectives. Some fun facts. Presenter Disclosure Information. Discuss the newest contraceptive options available

Learning objectives. Some fun facts. Presenter Disclosure Information. Discuss the newest contraceptive options available 2:15 3pm Advances and Options in Female Contraception SPEAKER Pelin Batur, MD, FACP, NCMP, CCD Presenter Disclosure Information The following relationships exist related to this presentation: Pelin Batur,

More information

Real life issues & answers: The hormonal patient Defining best practice, 5 key issues & case study

Real life issues & answers: The hormonal patient Defining best practice, 5 key issues & case study Real life issues & answers: The hormonal patient Defining best practice, 5 key issues & case study Dr Louise Newson BSc(Hons) MBChB(Hons) MRCP FRCGP www.menopausedoctor.co.uk Case Number 1 - Claire Age

More information

Contraception Choices: An Evidence Based Approach Case Study Approach. Susan Hellier PhD, DNP, FNP-BC, CNE

Contraception Choices: An Evidence Based Approach Case Study Approach. Susan Hellier PhD, DNP, FNP-BC, CNE Contraception Choices: An Evidence Based Approach Case Study Approach Susan Hellier PhD, DNP, FNP-BC, CNE Objectives Describe the U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 (U.S. MEC)

More information

CLINICAL PEARLS IN CONTRACEPTION

CLINICAL PEARLS IN CONTRACEPTION CLINICAL PEARLS IN CONTRACEPTION Laura Borgelt, PharmD, FCCP, BCPS Associate Professor University of Colorado Denver PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as

More information

Linda Gregg NP, Janet Isabell NP, Sue Montei NP Clinical Reviewers Reproductive Health Unit

Linda Gregg NP, Janet Isabell NP, Sue Montei NP Clinical Reviewers Reproductive Health Unit Linda Gregg NP, Janet Isabell NP, Sue Montei NP Clinical Reviewers Reproductive Health Unit What We Plan To Do Describe the U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 (U.S. MEC) Explain

More information

Menopausal Symptoms. Hormone Therapy Products Available in Canada for the Treatment of. Physician Desk Reference - 3rd Edition

Menopausal Symptoms. Hormone Therapy Products Available in Canada for the Treatment of. Physician Desk Reference - 3rd Edition Hormone Therapy Products Available in Canada for the Treatment of Menopausal Symptoms Physician Desk Reference - 3rd Edition A clinical resource provided to you by: The Society of Obstetricians and Gynaecologists

More information

Product Information. Confidence that lasts

Product Information. Confidence that lasts Confidence that lasts What is Mirena? Inhibition of sperm motility and function inside the uterus and the fallopian tubes, preventing fertilization (Videla-Rivero et al. 1987). Section of system Levonorgestrel

More information

25 mg oestradiol implants--the dosage of first choice for subcutaneous oestrogen replacement therapy?

25 mg oestradiol implants--the dosage of first choice for subcutaneous oestrogen replacement therapy? Research Subcutaneous estrogen replacement therapy. Jones SC. Journal of Reproductive Medicine March, 2004; 49(3):139-142. Department of Obstetrics and Gynecology, Keesler Medical Center, Keesler Air Force

More information

OVERVIEW OF MENOPAUSE

OVERVIEW OF MENOPAUSE OVERVIEW OF MENOPAUSE Nicole Budrys, MD, MPH Reproductive Endocrinology Michigan Center for Fertility and Women s Health Presented at SEMCME March 13,2019 Objectives Define menopause Etiology of menopause

More information

Reproductive System. Testes. Accessory reproductive organs. gametogenesis hormones. Reproductive tract & Glands

Reproductive System. Testes. Accessory reproductive organs. gametogenesis hormones. Reproductive tract & Glands Reproductive System Testes gametogenesis hormones Accessory reproductive organs Reproductive tract & Glands transport gametes provide nourishment for gametes Hormonal regulation in men Hypothalamus - puberty

More information

Intrauterine delivery of progestogen in the peri- and postmenopausal women. Outline of the presentation. Levonorgestrel releasing IUS - Mirena

Intrauterine delivery of progestogen in the peri- and postmenopausal women. Outline of the presentation. Levonorgestrel releasing IUS - Mirena QuickTime ja Valokuva - JPEG pakkauksen purkuohjelma tarvitaan elokuvan katselemiseen. Intrauterine delivery of progestogen in the peri- and postmenopausal women ESHRE Campus meeting 6.-7.10.2008 Oskari

More information

2

2 1 2 3 1. Usinger KM et al. Intrauterine contraception continuation in adolescents and young women: a systematic review. J Pediatr Adolesc Gynecol 2016; 29: 659 67. 2. Kost K et al. Estimates of contraceptive

More information

Clinical Policy: Goserelin Acetate (Zoladex) Reference Number: ERX.SPA.145 Effective Date:

Clinical Policy: Goserelin Acetate (Zoladex) Reference Number: ERX.SPA.145 Effective Date: Clinical Policy: (Zoladex) Reference Number: ERX.SPA.145 Effective Date: 10.01.16 Last Review Date: 11.17 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

Disclosures. Learning Objectives 4/18/2017 ADOLESCENT CONTRACEPTION UPDATE APRIL 28, Nexplanon trainer for Merck

Disclosures. Learning Objectives 4/18/2017 ADOLESCENT CONTRACEPTION UPDATE APRIL 28, Nexplanon trainer for Merck ADOLESCENT CONTRACEPTION UPDATE APRIL 28, 2017 Brandy Mitchell, MN, RN, ANP BC, WHNP BC University of Iowa Hospitals and Clinics Obstetrics and Gynecology Iowa Association of Nurse Practitioners Spring

More information

Conflicts 10/5/2016. Abnormal Uterine Bleeding. Objectives Review diagnosis and updated nomenclature. Management options for acute and chronic AUB.

Conflicts 10/5/2016. Abnormal Uterine Bleeding. Objectives Review diagnosis and updated nomenclature. Management options for acute and chronic AUB. Abnormal Uterine Bleeding Barbara L. Keller, MD JD Naval Hospital Oak Harbor OB/GYN Physician Conflicts I have no conflicts or financial interests to disclose. Objectives Review diagnosis and updated nomenclature.

More information

Transgender Medicine beyond the guidelines.

Transgender Medicine beyond the guidelines. Transgender Medicine beyond the guidelines. Rachel Hopkins, MD Assistant Professor of Medicine SUNY Upstate Medical University Division of Endocrinology and Metabolism Overview Definitions and history

More information

Contraceptive case studies. Dr Christine Roke National Medical Advisor Family Planning June 2015

Contraceptive case studies. Dr Christine Roke National Medical Advisor Family Planning June 2015 Contraceptive case studies Dr Christine Roke National Medical Advisor Family Planning June 2015 Case 1 Mary is a 47 year old who has come in for a routine cervical smear. She asks when her Multiload IUD

More information

Hormonal Contraception: Asian View. Hormonal Contraception: Asian View: focused on Chinese View. Prof.Dr.Xiangyan Ruan, MD.PhD

Hormonal Contraception: Asian View. Hormonal Contraception: Asian View: focused on Chinese View. Prof.Dr.Xiangyan Ruan, MD.PhD Asian View Prof.Dr.Xiangyan Ruan, MD.PhD Beijing Obstetrics & Gynecology Hospital, Capital Medical University (China) WHO Collaborative Centre - Director of Dept. of Gynecological Endocrinology & & - Fertility

More information

Post-menopausal hormone replacement therapy. Evan Klass, MD May 17, 2018

Post-menopausal hormone replacement therapy. Evan Klass, MD May 17, 2018 Post-menopausal hormone replacement therapy Evan Klass, MD May 17, 2018 Are we really still talking about this? Are we really still talking about this? 1960-1975- estrogen prescriptions doubled. Pharma

More information

The Truth About Birth Control

The Truth About Birth Control The Truth About Birth Control This is not so much about right or wrong It is important to provide clients with the best information Adding hormones to a women s body is bothersome The goal is to educate

More information

Contraception. Objectives. Unintended Pregnancy. Unintended Pregnancy in the US. What s the Impact? 10/7/2014

Contraception. Objectives. Unintended Pregnancy. Unintended Pregnancy in the US. What s the Impact? 10/7/2014 Contraception Tami Allen, RNC OB, MHA Robin Petersen, RN, MSN Perinatal Clinical Nurse Specialist Objectives Discuss the impact of unintended pregnancy in the United States Discuss the risks and benefits

More information

Instructions how to use the ESC teach the teachers course and self-learning tool

Instructions how to use the ESC teach the teachers course and self-learning tool Instructions how to use the ESC teach the teachers course and self-learning tool Welcome to the ESC advanced learning tool To improve and facilitate knowledge and use of contraception, abortion, sexually

More information

1. Ng M et a l. Global, regional, and national prevalence of overweight and obesity in children and adults during : A systematic analysis

1. Ng M et a l. Global, regional, and national prevalence of overweight and obesity in children and adults during : A systematic analysis 1 2 3 1. Ng M et a l. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980 2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet

More information

levonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer

levonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer levonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer 6 March 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises

More information

Menopause management NICE Implementation

Menopause management NICE Implementation Menopause management NICE Implementation Dr Paula Briggs Consultant in Sexual & Reproductive Health Southport and Ormskirk NHS Hospital Trust Why a NICE guideline (NG 23) Media reports about HRT have not

More information

World Health Organization Medical Eligibility for Contraceptive Use. Connie Kraus, PharmD, BCACP Professor (CHS) Director Office of Global Health

World Health Organization Medical Eligibility for Contraceptive Use. Connie Kraus, PharmD, BCACP Professor (CHS) Director Office of Global Health World Health Organization Medical Eligibility for Contraceptive Use Connie Kraus, PharmD, BCACP Professor (CHS) Director Office of Global Health Objectives After this session, learners should be able to:

More information

Effective Contraception Utilization. Sarah Laiosa, DO Family Physician Contract Medical Director, EOCCO

Effective Contraception Utilization. Sarah Laiosa, DO Family Physician Contract Medical Director, EOCCO Effective Contraception Utilization Sarah Laiosa, DO Family Physician Contract Medical Director, EOCCO Disclosures Contract Medical Director, EOCCO Objectives Illustrate how to best address contraception

More information

Contraception for Adolescents: What s New?

Contraception for Adolescents: What s New? Contraception for Adolescents: What s New? US Medical Eligibility Criteria for Contraceptive Use Kathryn M. Curtis, PhD Division of Reproductive Health, CDC Expanding Our Experience and Expertise: Implementing

More information

Application for inclusion of levonorgestrel - releasing IUD for contraception in the WHO Model List of Essential Medicines

Application for inclusion of levonorgestrel - releasing IUD for contraception in the WHO Model List of Essential Medicines Application for inclusion of levonorgestrel - releasing IUD for contraception in the WHO Model List of Essential Medicines 1. Summary statement of the proposal for inclusion LNG-IUS is an effective contraceptive;

More information

MEASURE #3: PREVENTIVE MIGRAINE MEDICATION PRESCRIBED Headache

MEASURE #3: PREVENTIVE MIGRAINE MEDICATION PRESCRIBED Headache MEASURE #3: PREVENTIVE MIGRAINE MEDICATION PRESCRIBED Headache Measure Description Percentage of patients age 18 years old and older diagnosed with migraine headache whose migraine frequency is 4 migraine

More information

WEIGHT GAIN DURING MENOPAUSE EMERGING RESEARCH

WEIGHT GAIN DURING MENOPAUSE EMERGING RESEARCH MENOPAUSE WHEN DOES IT OCCUR? The cessation of the menstrual cycle for one year. WEIGHT GAIN DURING MENOPAUSE EMERGING RESEARCH Jan Schroeder, Ph.D. Chair of The Department of Kinesiology California State

More information

How do we treat migraine? New SIGN Guidelines

How do we treat migraine? New SIGN Guidelines How do we treat migraine? New SIGN Guidelines Managing your migraine Migraine Trust, Edinburgh 2018 Callum Duncan Consultant Neurologist Aberdeen Royal Infirmary Chair SIGN Guideline 155 Premonitory Mood

More information

The Doctor Is In. Brent N Davidson MD Vice Chair Women s Health Henry Ford Health System Medical Director Family Planning MDCH

The Doctor Is In. Brent N Davidson MD Vice Chair Women s Health Henry Ford Health System Medical Director Family Planning MDCH The Doctor Is In Brent N Davidson MD Vice Chair Women s Health Henry Ford Health System Medical Director Family Planning MDCH Contraception Resources from the CDC: 2016 U.S. Medical Eligibility Criteria

More information